Analysis

Compugen Ltd. (CGEN) Stock Analysis

Compugen Ltd. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to CGEN.

websiteCGEN/analysis/CGEN

Compugen Ltd.

Compugen Ltd. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to CGEN.

Stock profile

Ticker

CGEN

Asset type

Stock

Market cap

$190.1M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Compugen Ltd. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • CGEN primary listing
  • CW9

Latest Compugen Ltd. news

Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI/ML, today presented a ...

Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026

Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress

Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by AI/ML, today announced that ma...

Compugen Reports First Quarter 2026 Results

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by AI/ML, today reported financia...

Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by AI/ML, today announced that ma...

Research sections

Valuation

Review valuation context for Compugen Ltd..

Future growth

Review future growth context for Compugen Ltd..

Past performance

Review past performance context for Compugen Ltd..

Financial health

Review financial health context for Compugen Ltd..

Dividend

Review dividend context for Compugen Ltd..

Management

Review management context for Compugen Ltd..

Ownership

Review ownership context for Compugen Ltd..

Other information

Review other information context for Compugen Ltd..

Community

Review community context for Compugen Ltd..